Results 11 to 20 of about 6,304 (197)

Household-level effects of seasonal malaria chemoprevention in the Gambia [PDF]

open access: yesCommunications Medicine, 2023
Background In 2022 the WHO recommended the discretionary expansion of the eligible age range for seasonal malaria chemoprevention (SMC) to children older than 4 years.
Seyi Soremekun   +11 more
doaj   +6 more sources

Seasonal malaria chemoprevention in northern Mozambique: a cost-effectiveness analysis [PDF]

open access: goldMalaria Journal
Background Malaria is endemic in Mozambique and one of the leading causes of death in children under 5 years old. In 2020 the country adopted the WHO-recommended seasonal malaria chemoprevention (SMC) strategy and delivered the intervention in all 23 ...
Neide Canana   +9 more
doaj   +5 more sources

Prevalence of malaria in an area receiving seasonal malaria chemoprevention in Niger [PDF]

open access: goldMalaria Journal, 2021
Background Malaria transmission is highly seasonal in Niger. Despite the introduction of seasonal malaria chemoprevention (SMC) in the Magaria District, malaria incidence remains high, and the epidemiology of malaria in the community is not well ...
Matthew E. Coldiron   +11 more
doaj   +4 more sources

Seasonal malaria chemoprevention: successes and missed opportunities [PDF]

open access: goldMalaria Journal, 2017
Seasonal malaria chemoprevention (SMC) was recommended in 2012 for young children in the Sahel during the peak malaria transmission season. Children are given a single dose of sulfadoxine/pyrimethamine combined with a 3-day course of amodiaquine, once a ...
Matthew E. Coldiron   +2 more
doaj   +5 more sources

Systematic review on the cost of seasonal malaria chemoprevention (SMC). [PDF]

open access: yesMalar J
Background Implemented in 17 countries to date, seasonal malaria chemoprevention (SMC) is a recommended strategy to prevent childhood malaria in areas with seasonal transmission of P.
Ruisch A   +7 more
europepmc   +5 more sources

Systematic Review and Meta-Analysis of Seasonal Malaria Chemoprevention. [PDF]

open access: yesAm J Trop Med Hyg, 2023
. Seasonal malaria chemoprevention (SMC) for children under 5 years of age for up to four monthly cycles during malaria transmission season was recommended by the WHO in 2012 and has been implemented in 13 countries in the Sahel, reaching more than 30 ...
Thwing J   +3 more
europepmc   +4 more sources

Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention [PDF]

open access: bronzeNew England Journal of Medicine, 2021
Malaria control remains a challenge in many parts of the Sahel and sub-Sahel regions of Africa.We conducted an individually randomized, controlled trial to assess whether seasonal vaccination with RTS,S/AS01E was noninferior to chemoprevention in preventing uncomplicated malaria and whether the two interventions combined were superior to either one ...
Daniel Chandramohan   +29 more
semanticscholar   +6 more sources

Phase one of a hybrid effectiveness-implementation study to assess the feasibility, acceptability and effectiveness of implementing seasonal malaria chemoprevention in Nampula Province, Mozambique [PDF]

open access: goldMalaria Journal
Background Seasonal malaria chemoprevention (SMC) is a highly effective intervention for malaria prevention in high burden areas with seasonal transmission, historically implemented in the Sahel.
Kevin Baker   +14 more
doaj   +3 more sources

Plasmodium falciparum dhps and dhfr markers of resistance to sulfadoxine-pyrimethamine five years (2016-2020) after the implementation of seasonal malaria chemoprevention in Cameroon. [PDF]

open access: goldWellcome Open Res
Background Antimalarial drug resistance is a major challenge in the fight against malaria. Cameroon implemented seasonal malaria chemoprevention (SMC) with sulfadoxine–pyrimethamine and amodiaquine (SPAQ) to over 1.5 million children aged 3–59 months ...
Tchuenkam PVK   +14 more
europepmc   +3 more sources

Receipt of seasonal malaria chemoprevention by age-ineligible children and associated factors in nine implementation states in Nigeria [PDF]

open access: yesMalaria Journal
Background As part of implementation quality standards, community distributors are expected to ensure that only age-eligible children (aged 3–59 months) receive seasonal malaria chemoprevention (SMC) medicines during monthly campaigns.
Taiwo Ibinaiye   +8 more
doaj   +3 more sources

Home - About - Disclaimer - Privacy